Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Rocket Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- +16 vs. Q4 2025
- Shares held
- 97.2M
- +14.5M (+17.5%) vs. Q4 2025
- Total value
- $347.9M
- +$57.8M (+19.9%) vs. Q4 2025
- New holders
- 48
- 81 more added
- Sold out
- 32
- 52 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $340.9M |
| Q1 2026 | 199 | $347.9M |
| Q4 2025 | 186 | $320.0M |
| Q3 2025 | 173 | $314.8M |
| Q2 2025 | 196 | $233.0M |
| Q1 2025 | 236 | $722.5M |
| Q4 2024 | 225 | $1.38B |
| Q3 2024 | 192 | $1.71B |
| Q2 2024 | 178 | $1.96B |
| Q1 2024 | 185 | $2.48B |
| Q4 2023 | 194 | $2.67B |
| Q3 2023 | 175 | $1.83B |
| Q2 2023 | 164 | $1.52B |
| Q1 2023 | 163 | $1.34B |
| Q4 2022 | 168 | $1.49B |
| Q3 2022 | 164 | $1.10B |
| Q2 2022 | 147 | $891.6M |
| Q1 2022 | 149 | $1.02B |
| Q4 2021 | 148 | $1.38B |
| Q3 2021 | 147 | $1.85B |
| Q2 2021 | 150 | $2.74B |
| Q1 2021 | 173 | $2.75B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Rocket Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −1,864,651−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −1,586,076−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,299,991−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −499,331−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −348,803−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −242,169−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −219,973−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −187,401−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −149,413−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −109,797−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −96,354−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −92,058−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −89,130−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −73,743−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −65,376−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −50,970−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −42,495−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −38,110−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −36,836−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −36,480−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −28,236−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −22,079−100.0% | Sold out |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −13,581−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,038−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,662−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −736−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −304−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −89,700−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |